Authors
Latest:
Cellular evidence of retinal ganglion cell transfection after LHON treatmentData show transfection in both eyes despite unilateral injection
Latest:
The rationale for enabling nurses to inject dexamethasone implantsNurses and other allied healthcare professionals can safely and effectively deliver intravitreal steroid implants in a clean room setting, which has reduced patient waiting times.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Using swept-source OCT and OCT angiography to image choroidal tumoursSS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Latest:
Ophthalmology and the climate crisis: Time to take responsibilityThe healthcare sector has high greenhouse gas emissions, to which ophthalmology is a significant contributor. Reducing waste, reusing instruments and medication and increasing our use of telemedicine can all contribute to reducing the carbon footprint of our specialty.
Latest:
ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision GroupAnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.
Latest:
Small-aperture IOL yields high satisfaction in retrospective reviewThe IC-8 IOL uses the small-aperture concept to extend cataract patients’ depth of focus. Patients report high approval and reduced spectacle dependence.
Latest:
It takes a village to beat visual system diseases in childrenCommunity support is the most important factor in ascertaining effective treatments for paediatric eye diseases.
Latest:
The truth about invisible posterior vitreous structuresUnderstanding vitreomacular interface diseases is key to treatment.
Latest:
Cerebral visual impairment: Documenting visual effects and simplifying visual lifeWith investigations into CVI in the early phases, collaboration across the Atlantic is crucial
Latest:
Real-world experience of OCT-A for retinal diagnoses and managementAs OCT-A devices become faster, the algorithms advance and the instrument costs decrease, more widespread utilisation in retina practices is likely.
Latest:
Optimizing Care For Patients With Retinal DisordersKey takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
Latest:
The complicated ins and outs of paediatric glaucomaEarly detection and diagnosis are key for these young patients
Latest:
New IOL offers patients greater spectacle independence over wider rangePatients desire spectacle independence at all distances. Early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.
Latest:
Personalising glaucoma surgery: The role of MIGSMinimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Latest:
A simple solution for complex corneasCorneal aberrations may occur more frequently than is generally appreciated, and they affect the visual outcomes following cataract surgery. Small-aperture optics provide a solution for a large category of patients who are otherwise not well served by complex IOLs.
Latest:
Expert on floppy iris syndrome offers practical pearls for successStrategies for the management and prevention of floppy iris syndrome include intraoperative interventions and recommendations on alternatives to tamsulosin for medical therapy in men with cataracts.
Latest:
IRISS registry study offers real-world outcomesInvestigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.
Latest:
ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World LeadersOWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.
Latest:
Repeatable, high-quality imaging leads to better diabetic eye disease managementSD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Latest:
Current approaches to treatment of uveitis with autoimmune diseaseUnderlying autoimmune disease alters uveitis therapy.
Latest:
Personalising glaucoma surgery: The role of MIGSMinimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
Brolucizumab for neovascular AMD: Safety guidance and clinician perspectivesAlthough the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits.
Latest:
Using swept-source OCT and OCT angiography to image choroidal tumoursSS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Latest:
AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGSInvestigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures
Latest:
Stating the facts about combination myopia management treatmentsGrowing evidence supports dual therapy to slow progression.
